QQQ   355.08 (+0.87%)
AAPL   180.72 (+0.35%)
MSFT   336.69 (+1.24%)
META   273.15 (+0.20%)
GOOGL   125.07 (+1.09%)
AMZN   124.88 (+1.72%)
TSLA   215.64 (+3.91%)
NVDA   393.07 (-1.16%)
NIO   7.62 (+1.06%)
BABA   84.50 (+1.81%)
AMD   118.20 (-1.06%)
T   15.21 (-3.80%)
F   12.45 (+2.81%)
MU   69.24 (+0.22%)
CGC   0.82 (-1.52%)
GE   106.62 (+1.86%)
DIS   91.11 (+2.84%)
AMC   4.57 (+0.44%)
PFE   38.49 (+1.24%)
PYPL   64.03 (+1.55%)
NFLX   400.33 (-0.69%)
QQQ   355.08 (+0.87%)
AAPL   180.72 (+0.35%)
MSFT   336.69 (+1.24%)
META   273.15 (+0.20%)
GOOGL   125.07 (+1.09%)
AMZN   124.88 (+1.72%)
TSLA   215.64 (+3.91%)
NVDA   393.07 (-1.16%)
NIO   7.62 (+1.06%)
BABA   84.50 (+1.81%)
AMD   118.20 (-1.06%)
T   15.21 (-3.80%)
F   12.45 (+2.81%)
MU   69.24 (+0.22%)
CGC   0.82 (-1.52%)
GE   106.62 (+1.86%)
DIS   91.11 (+2.84%)
AMC   4.57 (+0.44%)
PFE   38.49 (+1.24%)
PYPL   64.03 (+1.55%)
NFLX   400.33 (-0.69%)
QQQ   355.08 (+0.87%)
AAPL   180.72 (+0.35%)
MSFT   336.69 (+1.24%)
META   273.15 (+0.20%)
GOOGL   125.07 (+1.09%)
AMZN   124.88 (+1.72%)
TSLA   215.64 (+3.91%)
NVDA   393.07 (-1.16%)
NIO   7.62 (+1.06%)
BABA   84.50 (+1.81%)
AMD   118.20 (-1.06%)
T   15.21 (-3.80%)
F   12.45 (+2.81%)
MU   69.24 (+0.22%)
CGC   0.82 (-1.52%)
GE   106.62 (+1.86%)
DIS   91.11 (+2.84%)
AMC   4.57 (+0.44%)
PFE   38.49 (+1.24%)
PYPL   64.03 (+1.55%)
NFLX   400.33 (-0.69%)
QQQ   355.08 (+0.87%)
AAPL   180.72 (+0.35%)
MSFT   336.69 (+1.24%)
META   273.15 (+0.20%)
GOOGL   125.07 (+1.09%)
AMZN   124.88 (+1.72%)
TSLA   215.64 (+3.91%)
NVDA   393.07 (-1.16%)
NIO   7.62 (+1.06%)
BABA   84.50 (+1.81%)
AMD   118.20 (-1.06%)
T   15.21 (-3.80%)
F   12.45 (+2.81%)
MU   69.24 (+0.22%)
CGC   0.82 (-1.52%)
GE   106.62 (+1.86%)
DIS   91.11 (+2.84%)
AMC   4.57 (+0.44%)
PFE   38.49 (+1.24%)
PYPL   64.03 (+1.55%)
NFLX   400.33 (-0.69%)
NASDAQ:OPRX

OptimizeRx (OPRX) Earnings Date, Estimates & Call Transcripts

$14.61
+0.38 (+2.67%)
(As of 03:03 PM ET)
Compare
Today's Range
$14.02
$14.72
50-Day Range
$11.63
$15.63
52-Week Range
$11.59
$30.82
Volume
79,646 shs
Average Volume
211,567 shs
Market Capitalization
$250.27 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$21.00

Earnings Summary

Skip Charts & View Estimated and Actual Earnings Data

OPRX Earnings Estimates and Actuals by Quarter

The chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.

OPRX Estimated and Actual Revenue by Quarter

The chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter.

OptimizeRx Analyst Forecasts

QuarterNumber of EstimatesLow EstimateHigh EstimateAverage EstimateCompany Guidance
Q1 20231($0.14)($0.14)($0.14) 
Q2 20231($0.24)($0.24)($0.24) 
Q3 20231$0.20$0.20$0.20 
Q4 20231$0.01$0.01$0.01 
FY 20234($0.17)($0.17)($0.17) 
Q1 20241($0.36)($0.36)($0.36) 
Q2 20241($0.24)($0.24)($0.24) 
Q3 20241($0.18)($0.18)($0.18) 
Q4 20241$0.04$0.04$0.04 
FY 20244($0.74)($0.74) ($0.74)

OPRX Earnings Date and Information

OptimizeRx last released its earnings results on March 8th, 2023. The reported $0.01 earnings per share (EPS) for the quarter. The company had revenue of $19.70 million for the quarter, compared to the consensus estimate of $21.84 million. OptimizeRx has generated ($0.79) earnings per share over the last year (($0.79) diluted earnings per share). Earnings for OptimizeRx are expected to grow in the coming year, from ($0.81) to ($0.74) per share. OptimizeRx has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Tuesday, August 8th, 2023 based off prior year's report dates.

OptimizeRx Earnings History by Quarter

DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueCall Transcript
8/8/2023
(Estimated)
        
5/10/2023Q1 2023($0.32)($0.34)($0.02)($0.31)$12.37 million$13.00 million
3/8/2023Q4 2022$0.01+$0.01$0.04$21.84 million$19.70 million
11/8/2022Q3 2022($0.18)($0.16)+$0.02($0.13)$15.16 million$15.09 million
8/9/2022Q2 2022($0.09)($0.18)($0.09)($0.15)$17.10 million$13.98 million
5/4/2022Q1 2022($0.08)($0.18)($0.10)($0.15)$13.78 million$13.73 million    
2/24/2022Q4 2021$0.09$0.03($0.06)$0.03$20.09 million$20.30 million    
11/9/20219/30/2021$0.13$0.09($0.04)$14.82 million$16.13 million    
8/4/20216/30/2021$0.02$0.10+$0.08$0.02$12.35 million$13.63 million    
5/6/2021Q1 2021($0.03)($0.01)+$0.02($0.06)$10.32 million$11.23 million
2/23/202112/31/2020$0.16$0.16$0.14$16.02 million$16.43 million  
11/9/2020Q3 2020($0.02)($0.01)+$0.01$10.04 million$10.52 million  
8/5/20206/30/2020($0.03)$0.02+$0.05($0.07)$8.02 million$8.78 million  
5/4/20203/31/2020($0.03)($0.06)($0.03)($0.15)$7.10 million$7.59 million  
2/27/2020Q4 2019($0.05)($0.03)+$0.02($0.06)$7.66 million$7.38 million  
11/5/2019Q3$0.04($0.11)($0.15)($0.11)$7.21 million$5.00 million  
8/7/2019Q2 2019$0.03$0.03$0.03$6.78 million$7.01 million
11/5/2018Q3 2018$0.01$0.02+$0.01$0.02$5.28 million$5.42 million
11/5/2018Q3$0.01$0.02+$0.01$0.02$5.28 million$5.42 million
8/7/2018Q2 2018($0.02)$0.02+$0.04$0.02$4.34 million$5.10 million
8/7/2018Q2 2018$0.02$0.02$0.02$4.34 million$5.10 million
5/2/2018Q1 2018($0.03)($0.03)($0.03)$4.11 million
5/2/2018Q1 2018($0.03)($0.03)($0.03)$4.11 million
2/27/2018Q4 2017($0.03)($0.03)($0.03)$4.01 million
2/27/2018Q4 2017($0.01)($0.01)($0.01)$4.01 million
11/2/2017Q3 2017($0.06)($0.06)($0.06)$3.10 million
11/2/2017Q3 2017($0.02)($0.02)($0.02)$3.10 million
8/1/2017Q2 2017($0.03)($0.03)($0.03)$2.87 million
8/1/2017Q2 2017($0.01)($0.01)($0.01)$2.87 million  
5/3/2017Q1 2017($0.09)($0.09)($0.09)$2.15 million
5/3/2017Q1 2017($0.03)($0.03)($0.03)$2.15 million  
3/8/2017Q4 2016($0.03)($0.03)($0.03)$2.29 million
3/8/2017Q4 2016($0.01)($0.01)($0.01)$2.29 million
11/7/2016Q3 2016($0.03)($0.03)($0.03)$1.79 million
11/7/2016Q3 2016($0.01)($0.01)($0.01)$1.79 million
8/8/2016Q2 2016($0.06)($0.06)($0.06)$2.05 million$1.91 million
8/8/2016Q2 2016($0.02)($0.02)($0.02)$2.05 million$1.91 million
5/9/2016Q1 2016($0.09)($0.03)+$0.06($0.03)$1.70 million$1.76 million
5/9/2016Q1 2016($0.09)($0.03)+$0.06($0.03)$1.70 million$1.76 million
3/15/2016Q4 2015($0.03)($0.03)($0.03)$2.30 million$2.02 million
3/15/2016Q4 2015($0.03)($0.03)($0.03)$2.30 million$2.02 million
8/11/2015Q2 2015($0.03)($0.03)($0.03)$1.92 million$1.71 million
8/11/2015Q2 2015($0.01)($0.01)($0.01)$1.92 million$1.71 million
3/31/2015Q4 2014$0.03$0.03$0.03$1.92 million$1.97 million
3/31/2015Q4 2014$0.03$0.03$0.03$1.92 million$1.97 million
11/13/2014Q3 2014($0.06)($0.06)($0.06)$1.71 million$1.62 million
11/13/2014Q3 2014($0.06)($0.06)($0.06)$1.71 million$1.62 million  
5/16/2014Q1 2014$0.03($0.12)($0.15)($0.12)$1.92 million$1.32 million
5/16/2014Q1 2014$0.03($0.12)($0.15)($0.12)$1.92 million$1.32 million
8/12/2013Q2 2013$0.06$0.03($0.03)$0.03$1.10 million$1.10 million
8/12/2013Q2 2013$0.02$0.01($0.01)$0.01$1.10 million$1.10 million
3/12/2013Q4 2012$0.01$0.01$0.01
5/15/2012Q1 2012($0.03)($0.02)+$0.01($0.02)












OptimizeRx Earnings - Frequently Asked Questions

When is OptimizeRx's earnings date?

OptimizeRx has not confirmed its next earnings publication date, but the company's estimated earnings date is Tuesday, August 8th, 2023 based off last year's report dates. Learn more on OPRX's earnings history.

How much revenue does OptimizeRx generate each year?

OptimizeRx (NASDAQ:OPRX) has a recorded annual revenue of $62.45 million.

How much profit does OptimizeRx generate each year?

OptimizeRx (NASDAQ:OPRX) has a recorded net income of -$11.44 million. OPRX has generated -$0.79 earnings per share over the last four quarters.

What is OptimizeRx's EPS forecast for next year?

OptimizeRx's earnings are expected to grow from ($0.81) per share to ($0.74) per share in the next year.

More Earnings Resources from MarketBeat

This page (NASDAQ:OPRX) was last updated on 6/2/2023 by MarketBeat.com Staff

My Account -